Aditxt's average Accounts Receivable for the
three
months ended in Mar. 2025 was $0.04 Mil. Aditxt's Revenue for the
three
months ended in Mar. 2025 was $0.00 Mil.
Hence, Aditxt's Days Sales Outstanding for the
three
months ended in Mar. 2025 was 3,878.13.
The historical rank and industry rank for Aditxt's Days Sales Outstanding or its related term are showing as below:
ADTX'
s Days Sales Outstanding Range Over the Past 10 Years
Min: 120.75 Med: 288.85 Max: 1615.29
Current: 1615.29
During the past 8 years, Aditxt's highest Days Sales Outstanding was 1615.29. The lowest was 120.75. And the median was 288.85.
ADTX's Days Sales Outstanding is ranked worse than 97.52% of 848
companies
in the Biotechnology industry
Industry Median: 70.36
vs ADTX: 1615.29
Aditxt's Days Sales Outstanding
increased
from Mar. 2024 (476.21) to Mar. 2025 (3,878.13).
Warning Sign:
If a company's sales outstanding increases, it means it has difficulty collecting payments from its customers.
Aditxt Days Sales Outstanding Historical Data
The historical data trend for Aditxt's Days Sales Outstanding can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Aditxt's Days Sales Outstanding
For the Biotechnology subindustry, Aditxt's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Aditxt's Days Sales Outstanding Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Aditxt's Days Sales Outstanding distribution charts can be found below:
* The bar in red indicates where Aditxt's Days Sales Outstanding falls into.
Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Aditxt (NAS:ADTX) Days Sales Outstanding Explanation
For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.
Aditxt Days Sales Outstanding Related Terms
Thank you for viewing the detailed overview of Aditxt's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.
Aditxt Inc is a life sciences company that develops, builds, and grows innovations with a focus on monitoring and modulating the immune system. It develops products designed to induce tolerance to transplanted organs. Its portfolio consists of two programs Adimune and AditxtScore. It firm's immunosuppressive (anti-rejection) drugs have made possible life-saving organ transplantation procedures and blocking of unwanted immune responses in autoimmune diseases. It is also developing a technology called Apoptotic DNA Immunotherapy (ADi) ADI-100, which utilizes a novel approach that mimics, the way bodies naturally induce tolerance to tissues.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
ADTX has been successfully added to your 